SignalPath raises $18m ahead of trial management platform expansion

By Vassia Barba

- Last updated on GMT

(Image: Getty/ipopba)
(Image: Getty/ipopba)

Related tags SignalPath Data management Clinical data management Clinical trial data

SignalPath announced the closing of its Series B funding round to support the expansion of its software platform, which facilitates clinical trials management.

SignalPath, a North Carolina, US-based software developer, has raised $18m (€16.18m) from existing investors, bringing its total capital to $35m (€31.46m), in order to support the expansion of its suite of tools available for clinical trial sites.

The company holds a software platform with tools allowing clinical data storage and management, with an aim to “reduce complexity, drive efficiency, improve quality, and increase transparency across the research ecosystem,”​ according to Brad Hirsch, the company’s CEO.

To date, approximately 250 clinical sites have access to the platform, with the volume of the network ultimately allowing the company to move on to developing insights about clinical research, a project which was previously ‘impossible to conduct’, Hirsch stated.

The funding is expected to support the development of software tools providing these insights, as well as to enable the growth of the company’s research teams.

In 2018, the company announced the launch of a research consortium, with the aim of bringing together technology companies, sponsors and researchers.

The company’s CEO told us then​ that the company aims to have integrated the use of real world data in clinical study design and management by 2020.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more